# Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers

> **NCT00933348** · PHASE2 · SUSPENDED · sponsor: **Phoenix Eagle Company** · enrollment: 30 (estimated)

## Conditions studied

- Venous Ulcer
- Pressure Ulcer

## Interventions

- **DRUG:** OPAL A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00933348
- **Lead sponsor:** Phoenix Eagle Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2010-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Slow recruitment caused rethink on the study design
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933348, "Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00933348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*